Delivery Order SPE2DB20D2014-SPE2DB25FA49U

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,647.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Firm Fixed Price, with an ultimate completion date of December 3, 2024. The award covers the supply of OXYCONTIN ER 20 MG TABLET 100S, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,582.62 firm fixed-price delivery order is for the supply of OXYCONTIN ER 20 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,668.68, is a delivery order for OXYCONTIN ER 30 MG TABLET 100S. The contract has an ultimate completion date of December 21, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $10,930.54, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 5, 2025. The contract provides for the delivery of OXYCONTIN ER 40 MG TABLET 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,716.54 with a Firm Fixed Price pricing type. The contract is for the delivery of OXYCONTIN ER 60 MG TABLET 100S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 21, 2024. The contract, valued at $6,526.80, is a firm fixed price delivery order for the supply of OXYCONTIN ER 10 MG TABLET 100S. The contract has an ultimate completion date of November 22, 2024 and was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,523.92, is a Delivery Order contract for the supply of Oxycontin ER 10 mg tablets. The contract has an ultimate completion date of December 27, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,989.41 and is a Firm Fixed Price Delivery Order that runs through March 2025. The contract covers the supply of OXYCONTIN ER 20 MG TABLET 100S, a prescription opioid medication, to support military and federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $9,348.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OXYCONTIN ER 60 MG TABLET 100S, a prescription pharmaceutical product, with a completion date of March 19, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,865.97 firm fixed-price delivery order is for the supply of OXYCONTIN ER 20 MG TABLET 100S. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA49U
    Delivery Order

This federal contract award is a delivery order valued at $5,878.69, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of OXYCONTIN ER 60 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 6, 2024 and utilizes a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating it was competitively awarded. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 1:57 PM